Crispr Therapeutics
Price & Volume
Stats
See more52W Range | $34.87-$78.48 |
Market Cap | $5.2B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $4.1M |
Revenue Growth (YoY) | 68.6% |
Gross Profit (12 Mos) | -$478.7M |
Diluted EPS | -$6.17 |
News
See moreYahoo Finance • yesterday
Cathie Wood buys $12.9 million of tumbling tech stock
Yahoo Finance • 7 days ago
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
Yahoo Finance • 8 days ago
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Yahoo Finance • 8 days ago
Is Mineralys Therapeutics, Inc. (MLYS) A Good Stock To Buy Now?
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |